This topic contains a solution. Click here to go to the answer

Author Question: A patient with a history of seizure disorders is receiving both ethosuximide (Zarontin) and ... (Read 196 times)

B

  • Hero Member
  • *****
  • Posts: 570
A patient with a history of seizure disorders is receiving both ethosuximide (Zarontin) and phen-ytoin (Dilantin). Assess the following serum laboratory test results, and select the one that would indicate an expected drug interaction.
 
  a. Increased ethosuximide concentration
  b. Decreased ethosuximide concentration
  c. Increased phenytoin concentration
  d. Decreased phenytoin concentration

Question 2

The patient is a 15-year-old who has a history of a poorly controlled seizure disorder. His primary care provider tells his parents that he is not a candidate for treatment with phenytoin.
 
  The decision is made based on the need to reduce the patient's risk of developing:
  a. Gingival hyperplasia
  b. Altered mental status
  c. Cardiac arrhythmias
  d. Craniofacial abnormalities



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Zebsrer

  • Sr. Member
  • ****
  • Posts: 284
Answer to Question 1

ANS: C
Succinimides, such as ethosuximide, interact with hydantoins, such as phenytoin, to increase se-rum hydantoin levels.

Answer to Question 2

ANS: A
Patients under 23 years of age and those taking phenytoin in dosages exceeding 500 mg/day are at increased risk for gingival hyperplasia.





 

Did you know?

A cataract is a clouding of the eyes' natural lens. As we age, some clouding of the lens may occur. The first sign of a cataract is usually blurry vision. Although glasses and other visual aids may at first help a person with cataracts, surgery may become inevitable. Cataract surgery is very successful in restoring vision, and it is the most frequently performed surgery in the United States.

Did you know?

The horizontal fraction bar was introduced by the Arabs.

Did you know?

Cyanide works by making the human body unable to use oxygen.

Did you know?

Warfarin was developed as a consequence of the study of a strange bleeding disorder that suddenly occurred in cattle on the northern prairies of the United States in the early 1900s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library